ANDA 214137, held by Teva Pharms USA Inc. Estradiol.
As of Nov 15, 2026, ANDA 214137 (Estradiol), held by Teva Pharms USA Inc, was first approved by FDA on Dec 8, 2025, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 8, 2025 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
